Searched over 200M research papers
10 papers analyzed
These studies suggest tumors can originate from chronic infections, distinct cells of origin, genetic variability, stem cells, and local or recruited structural cells.
20 papers analyzed
Tumors originate from normal cells that undergo tumorigenic transformation due to genetic mutations. These transformed cells, known as the cell-of-origin, acquire the first genetic hits that initiate cancer development . This process is characterized by the accumulation of genetic lesions that drive the transformation of normal cells into malignant ones.
Research indicates that many tumors arise from tissue stem cells. These stem cells, which are essential for normal tissue renewal, can become cancerous if they acquire specific genetic mutations. For instance, basal cell carcinomas (BCCs) of the skin have been shown to originate from hair follicle tissue stem cells. Similarly, chronic infection with carcinogens like Helicobacter can induce bone marrow-derived cells (BMDCs) to repopulate tissues and progress to cancer.
Tumor progression is often driven by clonal evolution, where a single cell of origin gives rise to a genetically diverse population of tumor cells. This genetic variability allows for the selection of more aggressive sublines, contributing to the complexity and heterogeneity of tumors. This process underscores the importance of understanding the evolutionary dynamics of tumor cells to develop effective treatments.
The tumor microenvironment plays a crucial role in supporting tumor growth. Non-neoplastic cells, such as tumor-associated fibroblasts (TAFs), are recruited to the tumor site to provide structural support, growth factors, and vascular networks. While some studies suggest that TAFs can originate from bone marrow-derived mesenchymal stem cells, others indicate that they predominantly come from local sources within the tumor microenvironment .
As tumors grow, some cells can detach and enter the bloodstream or lymphatic system, becoming circulating tumor cells (CTCs). These CTCs can travel to distant sites and potentially form new tumors, contributing to metastasis. Understanding the behavior and characteristics of CTCs is crucial for improving cancer diagnosis and treatment.
Tumors originate from normal cells that undergo genetic mutations, leading to malignant transformation. Stem cells play a significant role in this process, and the tumor microenvironment, including TAFs and CTCs, further supports tumor growth and metastasis. Understanding these origins and mechanisms is essential for developing targeted cancer therapies and improving patient outcomes.
Most relevant research papers on this topic